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Lacticin 3147 - a natural antimicrobial agent, can be used to control
microflora development during cheese-making to enhance flavour and
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Summary and Conclusions
Bacteriocins are proteins, produced by some bacteria which are capable of
inhibiting other bacteria.  The overall aim of this project was the
development and exploitation of bacteriocins such as Lacticin 3147
(produced by a food-grade microorganism), as biological tools to control the
microflora of foods. 
Lacticin 3147-producing strains were evaluated for their ability to improve
the microbial quality of a variety of dairy products and in particular,
Cheddar cheese. The manipulation of cheese flora using bacteriocins should
offer manufacturers greater control in the consistency and quality of the final
product, in addition to improving its safety.
In concert with these studies, Lacticin 3147 was studied in detail at the
molecular level resulting in its biochemical and genetic analysis. These
studies have demonstrated the complexity and uniqueness of this potent
antimicrobial.
Main conclusions and achievements 
*  Lacticin 3147 was shown to inhibit the dangerous food pathogen Listeria
monocytogenes Scott A in Cottage cheese.
The study demonstrated the effectiveness of Lacticin 3147 as an inhibitor of
L. monocytogenes in a food system where post-manufacture contamination
by this organism could present a risk to the consumer.
* Commercial cheese starter strains were successfully manipulated to
produce Lacticin 3147 without significantly affecting their cheese-making
properties.  This was confirmed by commercial scale trials. 
Simultaneously, Lacticin 3147-tolerant adjunct cultures were developed to
be used in conjunction with the Lacticin 3147-producing starter strains, for
enhancement of cheese flavour.
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This new technology facilitates greater control over the growth of cheese
microflora, which in turn should enhance flavour, quality and consistency.
*  Reduced fat Cheddar cheese manufactured with a Lacticin 3147 producer
can be ripened at an elevated temperature which can be difficult to achieve
with traditional starters due to spoilage by non-starter populations.
*  Biochemical analysis has identified unusual residues such as lanthionine,
dehydrated amino acids and D-alanine residues in Lacticin 3147.  This is the
first two-component, D-alanine containing lantibiotic reported to date,
demonstrating the uniqueness of this potent antimicrobial. 
*  The genes involved in Lacticin 3147
production and immunity have been cloned,
sequenced and through mutational analysis,
have been functionally characterised.  Such
analyses have demonstrated that:
- The two component peptides of
Lacticin 3147 require separate modification
enzymes for activity.
- The gene ltnI has been identified as
conferring immunity to Lacticin 3147.
- Lacticin 3147 uses a regulatory
mechanism not previously identified in
lantibiotic systems.
-  A role for Lacticin 3147 as a food-
grade selectable marker has been
demonstrated.
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Fig. 1: Lacticin 3147 activity in
cheese during 6 months of
ripening.
Research and Results
Members of the lactic acid bacteria play an essential role in a wide variety
of food fermentations with Lactococcus subsp. being the primary starter
cultures exploited for Cheddar cheese manufacture.  In addition, a
population of adventitious microflora, otherwise known as non-starter lactic
acid bacteria (NSLAB) can proliferate during ripening and often form the
dominant flora in the cheese.
The precise role of NSLAB strains in flavour development remains unclear,
however whether positive or negative, they certainly contribute to the
unpredictability associated with Cheddar cheese quality.  Importantly,
NSLABs have also been associated with defects in cheese such as the
formation of calcium lactate crystals and slit formation.
Given increasing consumer demand, the challenge now facing the
cheesemaker is the development of a safe, well-flavoured, consistent
Cheddar.  One approach to improving cheese flavour has been the
deliberate addition of selected, adjunct lactobacilli during manufacture
which would impart beneficial qualities. Although some studies reported
cheese with improved flavour, other adjunct cultures were responsible for
flavour defects.  In addition, comparisons with control vats were difficult to
interpret due to contamination with the adjunct strain or with adventitious
NSLABs, which eventually reach levels similar to the test vat.
Hence, in order to study the relevance of NSLABs, as well as examining the
role of adjunct cultures in Cheddar flavour, there is a requirement for an
effective and simple method of controlling adventitious strains during
manufacture and ripening. 
Consequently, the known ability of Lacticin 3147-producing lactococcal
starters to inhibit NSLABs during cheese ripening has been exploited and
evaluated in these studies.
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Use of Lacticin-producing starters in cheese-making
Cheddar
The bacteriocin Lacticin 3147 inhibits a broad-range of Gram positive
bacteria including food pathogenic and spoilage organisms such as Listeria,
Clostridia and Staphylococci and formed the focus of this research project.
The genes encoding Lacticin 3147 are located on a conjugative plasmid,
pMRC01 and during the course of this project the genetic determinants for
Lacticin 3147 were transferred to a range of commercial cheese starters with
the aim of generating a bank of improved bacteriocin-producing starter
cultures. 
6
Fig. 2: Growth of non-starter lactic acid bacteria in reduced fat Cheddar cheese - a) open
symbols: ripened at 7ºC and b) filled symbols: ripened at 12ºC.  Blue and green lines
represent counts for control cheeses, manufactured in the absence of Lacticin 3147
producng strains.  Red lines represent counts of non-starter lactic acid bacteria in cheese
manufactured with a Lacticin 3147 producer.
Importantly these strains are not GMOs as they were generated by natural
matings between bacteria. 
These Lacticin 3147 producing strains were evaluated for their ability to
influence the developing non-starter bacterial population in cheese.
In all pilot and commercial scale trials performed, results indicate that these
strains can be used to successfully manufacture Cheddar as they reduce the
pH within the desired time period.  Furthermore, the level of Lacticin 3147
in the cheese remained constant throughout ripening and correlated with
significant reductions in the levels of adventitious microflora. 
Reduced Fat Cheddar
A Lacticin 3147-producing transconjugant strain was also evaluated in
reduced fat Cheddar which was ripened at the elevated temperature of
12ºC with the aim of controlling NSLAB populations.
Pilot-scale trials demonstrated that even though the rate of NSLAB growth
was significantly increased at this temperature, sufficient Lacticin 3147 was
produced to markedly reduce NSLAB proliferation in experimental vats,
thereby providing a means of controlling the developing microflora at
increased ripening temperatures.  The significance of these results is that
cheese may be ripened at higher temperatures if Lacticin 3147 producing
starters are used in manufacture.  This may yield improvements in
flavour/quality since the vast majority of NSLABs are inhibited by Lacticin
3147.
Mould- and Smear-Ripened Cheese
In addition to their contribution to cheese quality, Lacticin 3147-producing
strains were also evaluated as surface protection cultures for the inhibition
of Listeria in mould- and smear-ripened cheese.  In recent years there has
been a number of high profile outbreaks of foodborne illness due to
ingestion of food contaminated with the pathogenic microorganism Listeria
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monocytogenes.  For this reason, a Lacticin 3147-producing strain was
investigated as a protective culture on the surface of mould-ripened and
smear-ripened cheese.  The Lacticin 3147-producing strain was sprayed
onto the surface of the cheese which was subsequently spiked with Listeria
monocytogenes. 
During ripening, microbiological analysis revealed significant reductions in
levels of listerial contamination in both cheese types.  The studies
demonstrate the potential of Lacticin 3147 producing strains for the
protection of cheese from contamination by Listeria.
Cottage Cheese
The efficacy of using a Lacticin 3147-producing starter to protect Cottage
cheese against contamination with the harmful human pathogen L.
monocytogenes Scott A was also investigated.  A Lacticin 3147-producing
strain was used as a starter in the manufacture of Cottage cheese which was
spiked with approximately 104
cfu/g L. monocytogenes Scott A. 
Lacticin 3147 activity was detected
throughout the 6-day storage
period and was associated with
1,000-fold reductions in Listeria
numbers in cheese stored at 4ºC.
The kill rate was even more rapid
in cheeses stored at higher
temperatures. These results
demonstrate the effectiveness of
Lacticin 3147 as an inhibitor of L.
monocytogenes in a food system
where post-manufacture
contamination by this organism
could be problematic.
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Fig. 3: Mould-ripened cheese.
Development of Cheese Adjunct Strains Tolerant to Lacticin 3147
In order to further manipulate cheese microflora, a Lactobacillus strain with
increased tolerance to Lacticin 3147 was generated by subculturing in
increasing concentrations of bacteriocin.  This strain, Lactobacillus
paracasei DPC5337 was assessed as a cheese-making adjunct with a
Lacticin 3147-producing starters and its performance was compared to the
sensitive parent, Lb. paracasei DPC5336. 
Pilot-scale trials were performed and in each case, the level of Lacticin 3147
activity in the cheese correlated with a reduction in NSLAB proliferation
9
Fig. 4: The survival of Listeria monocytogenes in Cottage cheese, manufactured in the
presence (    ) and absence (    ) of a Lacticin 3147-producing culture.
throughout ripening. In contrast, the tolerant adjunct strain survived the
concentration of Lacticin 3147 in the cheese, reaching counts of 107 CFU/g
during ripening, compared to the sensitive strain which was present at 104
to 105 CFU/g.  RAPD-PCR was employed to demonstrate that the tolerant
adjunct strain comprised the dominant microflora in the experimental
cheeses.
Hence, the use of Lacticin 3147-producing cultures in combination with
tolerant adjuncts may be exploited to yield a more predictable cheese
microflora which concomitantly improves product consistency.  Importantly,
this example demonstrates the versatility of Lacticin 3147 in providing a
useful tool to the cheesemaker, for the microbial control of cheese during
manufacture and ripening.
Expression of Lacticin 3147 in Enterococcus faecalis
Many hospital-acquired infections such as endocarditis have been linked to
Enterococcus faecalis, several strains of which produce a substance with
combined haemolytic/bactericidal activity, termed cytolysin.  Cytolysin is
composed of two peptides, both of which contain lanthionines.  These
peptides are encoded by large, pheromone-responsive, conjugative
plasmids such as pAD1, indicating a potential for transfer of cytolytic
capabilities to other bacteria.  Given its associated toxic nature, concern has
been raised for future protein engineering of lantibiotics since such
alterations could conceivably cause previously non-toxic bacteriocins to
acquire an activity against mammalian cells. 
Alternatively, it has been suggested that cytolysin may form the basis of a
potential therapeutic target in the control of such infections. 
Although cytolysin was the first two-peptide bacteriocin to be identified
among the lantibiotics, the more recent identification of Lacticin 3147 and
Staphylococcin C55 suggests that these complex, two-component systems
may be more widespread. Given the clinical significance of enterococcal
strains expressing cytolysin, it is of interest to compare the biological activity
of this bacteriocin to other two-component lantibiotic systems.
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The use of Lacticin 3147 as a biological tool for ensuring a predictable
microflora in Cheddar cheese.
Fig. 5: (A) The agar plates contain isolated colonies of the Lacticin 3147-producing strain,
Lactococcus lactis DPC3147 which are overlaid with a lawn of Lactobacillus paracasei
DPC5336 and DPC5337, respectively.  The absence of zones of inhibition in the Lb.
paracasei DPC5337 lawn indciates that this strain is tolerant to the levels of Lacticin 3147
produced by L. lactis DPC3147 colonies while strain Lb. paracasei DPC5336 remains
sensitive.  (B) The graph represents the bactericidal activity of Lacticin 3147 on Lb.paracasei
DPC5336 (  ) and  DPC5337 (  ).  Bacteriocin was added at a final concentration of 1,000
AU/ml to washed log-phase cells.  Controls to which no bacteriocin was added are
represented by Lb. paracasei DPC5336 (  ) and DPC5337 (  ).
In particular, since Lacticin 3147 and Lacticin 3147-producing strains show
considerable promise in food and biomedical applications it is important to
determine whether there are any undesirable features associated with this
lantibiotic. 
Although Lacticin 3147 is produced by a strain commonly used as a starter
in food fermentations and has been consumed safely for many years, it is
imperative to establish that the genes encoding this lantibiotic do not confer
toxic activity. Hence, a comparative study between the biological activities
of Lacticin 3147 and cytolysin was carried out. 
A plasmid containing the entire Lacticin 3147-encoding region was
constructed and designated pOM02. Expression of cytolysin (encoded by
pAD1) and Lacticin 3147 (encoded by pOM02) in an enterococcal
background facilitated the comparison of their respective activities against
eukaryotic and bacterial cells.
A study was performed to compare the biological activity of Lacticin 3147
with cytolysin.  The Lacticin 3147 encoding determinants were
heterologously expressed in Enterococcus faecalis FA2-2, a plasmid free
strain, to generate Enterococcus faecalis pOM02, thereby facilitating a direct
comparison with Enterococcus faecalis FA2-2.pAD1, a cytolysin producer.
Both heterologously expressed Lacticin 3147 and cytolysin exhibited a
broad spectrum of activity against bacterial targets.  Furthermore,
enterococci expressing active Lacticin 3147 did not exhibit haemolytic
activity against equine blood cells.  
The results indicated that the Lacticin 3147 biosynthetic machinery can be
heterologously expressed in an enterococcal background resulting in the
production of the bacteriocin with no detectable haemolytic activity.
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Biochemical and Genetic Analysis of Lacticin 3147
-  Lacticin 3147 is a novel, two component, D-alanine containing lantibiotic
that undergoes extensive post-translational modification which may account
for its potent antimicrobial activity against a wide range of Gram-positive
bacteria.
13
Fig. 6: Haemolytic assays demonstrate that heterologous expression of Lacticin 3147 in
Enterococcus faecalis FA2-2 does not result in lysis of equine bloods cells (d).  The parent
Lacticin 3147-producer strain Lactococcus lactis DPC3147 (a) and the plasmid-free strain,
Enterococcus faecalis FA2-2 (b) were plated as controls and do not exhibit haemolysis.
However, isolated colonies of Enterococcus faecalis FA2-2 pAD1, (cytolysin-producing) gave
rise to distinct zones of clearing as indciated in plate c.
-  Production and immunity of Lacticin 3147 is encoded by the 60.2 plasmid
pMRC01. The gene ltnI, encodes a 116 amino acid protein and
confirmation of the role of ltnI in immunity was obtained when it was
observed that disruption of ltnI resulted in a complete loss of immunity.
-  A role for Lacticin 3147 as a food-grade selectable marker has been
demonstrated. Results indicate that high expression levels of the immunity
gene, ltnI, confers a level of immunity which can be used to select for
transformants in the absence of an antibiotic selection. 
-  Each peptide of the two component lantibiotic Lacticin 3147 requires a
separate modification enzyme for activity.  Creation of a number of double
mutants confirmed that LtnM1 is required to produce mature LtnA1, while
LtnM2 is required to produce mature LtnA2.
-  Lacticin 3147 uses a regulatory mechanism not previously identified in
lantibiotic systems for the regulation of immunity.
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